Literature DB >> 4947349

Cytogenetic studies in malignant lymphomas: a study of 8 cases.

V Coutinho, C Bottura, R P Falcao.   

Abstract

Chromosome studies were carried out, by a direct method, in 28 subjects with malignant lymphomas. Lymph node cells were analysed in 24, ascitic fluid sediments in 3 and bone marrow cells in 1. Chromosome abnormalities, both numerical and structural, were found in 12 of 14 cases of well differentiated and poorly differentiated lymphocytic lymphomas, and reticulum cell sarcomas, and in 8 of 14 cases with Hodgkin's disease. The karyotypes were different from case to case and there was no correlation with the histology. In individual cases the abnormalities followed a clonal pattern indicating a common precursor for the abnormal cells. The modal number of chromosomes was near-diploid in the lymphocytic lymphomas and reticulum cell sarcomas.Hodgkin's disease showed two main features; a predominant population of cells with normal karyotype accompanied by a small number of cells of an abnormal clone with a predominantly hypertriploid number of chromosomes. It is suggested that the first population represents mitoses in the surrounding lymphocytes. Its cytogenetic normality is an argument against its neoplastic origin, and they could be components of an inflammatory reaction, the true neoplastic cells being the abnormal reticulum cells.

Entities:  

Mesh:

Year:  1971        PMID: 4947349      PMCID: PMC2008876          DOI: 10.1038/bjc.1971.93

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  11 in total

1.  CHROMOSOMES OF LYMPHOSARCOMA AND CANCER CELLS IN BONE MARROW.

Authors:  A A SANDBERG; T ISHIHARA; Y KIKUCHI; L H CROSSWHITE
Journal:  Cancer       Date:  1964-06       Impact factor: 6.860

2.  ABNORMAL KARYOTYPE FINDINGS IN BONE MARROW AND LYMPH NODE ASPIRATES OF A PATIENT WITH MALIGNANT LYMPHOMA.

Authors:  J H TJIO; J C MARSH; J WHANG; F FREI
Journal:  Blood       Date:  1963-08       Impact factor: 22.113

3.  CHROMOSOMES IN SHORT-TERM CULTURES OF LYMPHOID TISSUE FROM PATIENTS WITH RETICULOSIS.

Authors:  M C BAKER; N B ATKIN
Journal:  Br Med J       Date:  1965-03-20

4.  Immunoglobulin synthesis by human reticulum sarcoma cells in vivo and during long-term culture in vitro.

Authors:  B D Clarkson; G J Thorbecke; E de Harven; C Miles
Journal:  Cancer Res       Date:  1969-04       Impact factor: 12.701

5.  Chromosome abnormalities in lymph node cells from patient with familial lymphoma. Loss of No. 3 chromosome and presence of large submetacentric chromosome in reticulum cell sarcoma tissue.

Authors:  T Kajii; R L Neu; L I Gardner
Journal:  Cancer       Date:  1968-07       Impact factor: 6.860

6.  Chromosomes and transformation of lymphocytes in lymphoproliferative disorders.

Authors:  S D Lawler; C R Pentycross; B R Reeves
Journal:  Br Med J       Date:  1968-10-26

7.  Cytogenetic studies in multiple myeloma: a study of fourteen cases.

Authors:  E M Tassoni; J R Durant; S Becker; B Kravitz
Journal:  Cancer Res       Date:  1967-04       Impact factor: 12.701

8.  Chromosome studies in chronic lymphocytic leukemia and lymphosarcoma.

Authors:  P H Fitzgerald; A Adams
Journal:  J Natl Cancer Inst       Date:  1965-06       Impact factor: 13.506

9.  Chromosome changes in Hodgkin's disease.

Authors:  G S Seif; A I Spriggs
Journal:  J Natl Cancer Inst       Date:  1967-09       Impact factor: 13.506

10.  [Chromosome anomalies in a non-neoplastic lymph node].

Authors:  G Caprio; A Nespolo; G Bonadonna
Journal:  Tumori       Date:  1966 Nov-Dec
View more
  3 in total

1.  Letter: X-trisomy associated with Hodgkin's disease.

Authors:  H Lech; B Polaniecka; L Wisniewski
Journal:  Br Med J       Date:  1974-03-16

2.  Cytogenetics of malignant lymphomas. Studies utilising a Giemsa-banding technique.

Authors:  B R Reeves
Journal:  Humangenetik       Date:  1973-12-10

3.  The biology of tumor growth in the non-Hodgkin's lymphomas. A dual parameter flow cytometry study of 220 cases.

Authors:  S E Shackney; A M Levine; R I Fisher; P Nichols; E Jaffe; W H Schuette; R Simon; C A Smith; S J Occhipinti; J W Parker
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.